Skip to main content
OpenTrials

Clinical trial condition

Haemophilia B

Explore clinical trials studying Haemophilia B. Study availability and eligibility vary by location and protocol.

45 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Haemophilia B trial results

Enrolling by Invitation

Post-Marketing Surveillance (All Case Surveillance) on Treatment With Alhemo® in Patients With Haemophilia A or Haemophilia B With Inhibitors

NCT06285071

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +10 more
Locations
  • Novo Nordisk Investigational Site Toshima City, Tokyo, Japan
  • Mutsu general hospital_Pediatrics Aomori, Japan
  • Kyushu university hospital_Pediatrics Fukuoka, Japan
  • Sapporo Tokushukai Hospital_Pediatrics Hokkaido, Japan
View Trial Details
Enrolling by Invitation

A Study Following Males With Haemophilia B on Prophylaxis With Refixia/REBINYN

NCT03745924

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • AKH - Klin. Abt. f. Haematologie u. Haemostaseologie Vienna, Austria
  • Cliniques universitaires Saint-Luc - Service Hématologie Brussels, Belgium
  • UZ Antwerpen - UZA - Kinderhemato-Oncologie Edegem, Belgium
  • UZ Leuven - Hart en Vaatziekten Leuven, Belgium
View all 30 locations
View Trial Details
Completed

Post-marketing Surveillance (Use Result Surveillance) With Refixia®

NCT03875547

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • Novo Nordisk Investigational Site Søborg, Denmark
  • Nagoya University Hospital_Blood Transfusion Aichi, Japan
  • Aomori Prefectural Central Hospital_Pediatrics Aomori, Japan
  • Matsudo City General Hospital_Pediatrics Chiba, Japan
View all 23 locations
View Trial Details
Completed

A Research Study Investigating Nonacog Beta Pegol (N9-GP) for Treatment and Prevention of Bleedings in Chinese People With Haemophilia B

NCT05365217

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • Beijing Children's Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
  • Fujian Medical University Union Hospital-Hematology Fuzhou, Fujian, China
  • Nanfang Hospital, Southern Medical University-Haematology Guangzhou, Guangdong, China
View all 15 locations
View Trial Details
Completed

Safety and Efficacy of Nonacog Beta Pegol (N9-GP) in Previously Untreated Patients With Haemophilia B

NCT02141074

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +9 more
Locations
  • Miller Children's Hospital Long Beach Long Beach, California, United States
  • Children's Hospital Los Angeles - Endocrinology Los Angeles, California, United States
  • Shands Hospital at the University of Florida Gainesville, Florida, United States
  • Nemours Chld Clnc Jacksonville Jacksonville, Florida, United States
View all 93 locations
View Trial Details
Completed

Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B.

NCT01467427

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +9 more
Locations
  • Children's Hospital Los Angeles - Endocrinology Los Angeles, California, United States
  • UC Davis Medical Center Sacramento, California, United States
  • Colorado Hemophilia & Thrombosis Center Aurora, Colorado, United States
  • Childrens National Medical Ctr Washington D.C., District of Columbia, United States
View all 51 locations
View Trial Details
Completed

A Study to Evaluate the Real-world Usage and Effectiveness of Elocta and Alprolix in Patients With Haemophilia A or B

NCT03055611

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +10 more
Locations
  • Swedish Orphan Biovitrum Reserach site Berlin, Germany
  • Swedish Orphan Biovitrum Reserach Site Blaubeuren Abbey, Germany
  • Swedish Orphan Biovitrum Research Site Bonn, Germany
  • Swedish Orphan Biovitrum Research Site Delmenhorst, Germany
View all 22 locations
View Trial Details
Completed

A Study to Evaluate the Real-world Effectiveness and Usage of Alprolix in Patients With Haemophilia B in France

NCT03655340

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • Swedish Orphan Biovitrum Research Site (CHU de Bordeaux) Bordeaux, France
  • Swedish Orphan Biovitrum Research Site Brest, France
  • Swedish Orphan Biovitrum Research Site Caen, France
  • Swedish Orphan Biovitrum Research Site Chambéry, France
View all 18 locations
View Trial Details
Completed

Management of Health-Related QoL Impairment, Including Pain, Depression and Anxiety, in People With Haemophilia A and B

NCT03276130

Conditions
Anxiety Disorders, Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, +16 more
Locations
  • Swedish Orphan Biovitrum Research Site Copenhagen, Denmark
  • Swedish Orphan Biovitrum Research Site Helsinki, Finland
  • Swedish Orphan Biovitrum Research Site Gothenburg, Sweden
  • Swedish Orphan Biovitrum Research Site Malmö, Sweden
View Trial Details

Related conditions